Modulation of antibiotic sensitivity and biofilm formation in Pseudomonas aeruginosa by interspecies signal analogues

Nat Commun. 2019 May 27;10(1):2334. doi: 10.1038/s41467-019-10271-4.

Abstract

Pseudomonas aeruginosa, a significant opportunistic pathogen, can participate in inter-species communication through signaling by cis-2-unsaturated fatty acids of the diffusible signal factor (DSF) family. Sensing these signals leads to altered biofilm formation and increased tolerance to various antibiotics, and requires the histidine kinase PA1396. Here, we show that the membrane-associated sensory input domain of PA1396 has five transmembrane helices, two of which are required for DSF sensing. DSF binding is associated with enhanced auto-phosphorylation of PA1396 incorporated into liposomes. Further, we examined the ability of synthetic DSF analogues to modulate or inhibit PA1396 activity. Several of these analogues block the ability of DSF to trigger auto-phosphorylation and gene expression, whereas others act as inverse agonists reducing biofilm formation and antibiotic tolerance, both in vitro and in murine infection models. These analogues may thus represent lead compounds to develop novel adjuvants improving the efficacy of existing antibiotics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use
  • Bacterial Proteins / genetics
  • Bacterial Proteins / metabolism*
  • Biofilms / drug effects
  • Disease Models, Animal
  • Drug Resistance, Bacterial
  • Fatty Acids, Unsaturated / metabolism*
  • Female
  • Gene Expression Regulation, Bacterial / drug effects
  • Gene Expression Regulation, Bacterial / immunology
  • Histidine Kinase / genetics
  • Histidine Kinase / metabolism*
  • Humans
  • Liposomes / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Microbial Sensitivity Tests
  • Mutagenesis
  • Phosphorylation
  • Polymyxins / pharmacology
  • Polymyxins / therapeutic use
  • Pseudomonas Infections / drug therapy*
  • Pseudomonas Infections / immunology
  • Pseudomonas Infections / microbiology
  • Pseudomonas aeruginosa / physiology*
  • Virulence Factors / genetics
  • Virulence Factors / metabolism

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Fatty Acids, Unsaturated
  • Liposomes
  • Polymyxins
  • Virulence Factors
  • Histidine Kinase